CUSIP: 29664WAB1
What is CUSIP 29664WAB1?
CUSIP 29664WAB1 identifies 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 29664WAB1:
As of 31 Dec 2025, 0 institutional investors reported holding $0 in principal (par value) of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $0 | $0 | -$40,994,280 | 0 | |
| 2025 Q3 | $28,696,440 | $40,994,280 | +$186,254 | 99.8% | 9 |
| 2025 Q2 | $21,445,940 | $40,691,968 | +$258,902 | 98.57% | 11 |
| 2025 Q1 | $17,805,940 | $37,176,006 | +$4,762,266 | 98.3% | 9 |
| 2024 Q4 | $33,246,000 | $32,179,247 | -$171,476,277 | 96.97% | 6 |
| 2024 Q3 | $206,228,879 | $255,900,035 | -$4,680,942 | 94.87% | 16 |
| 2024 Q2 | $152,469,254 | $187,829,878 | +$194,776 | 92.31% | 18 |
| 2024 Q1 | $168,363,404 | $171,853,927 | -$14,901,542,141 | 83.01% | 17 |
| 2023 Q4 | $210,454,000 | $122,864,861 | +$10,846,961 | 58.34% | 18 |
| 2023 Q3 | $192,120,851 | $110,572,628 | -$4,399,266 | 52.0% | 17 |
| 2023 Q2 | $198,299,351 | $109,095,639 | -$6,106,943 | 49.71% | 18 |
| 2023 Q1 | $236,594,851 | $103,500,121 | -$397,411 | 40.06% | 20 |
| 2022 Q4 | $235,496,164 | $132,860,346 | +$4,389,560 | 54.96% | 20 |
| 2022 Q3 | $214,894,764 | $128,456,175 | -$42,773 | 55.78% | 19 |
| 2022 Q2 | $214,994,764 | $125,766,000 | +$772,275 | 54.43% | 19 |
| 2022 Q1 | $212,146,264 | $118,647,578 | +$5,205,374 | 51.57% | 20 |
| 2021 Q4 | $199,553,764 | $115,520,638 | +$115,520,638 | 52.75% | 17 |